Dexcom Announces Upcoming Conference Presentations
September 01 2022 - 4:15PM
Business Wire
DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain,
Executive Vice President and Chief Financial Officer, will present
an update on the company at the following upcoming investor
conferences:
- Wells Fargo 2022 Healthcare Conference on Wednesday, September
7, 2022 at 2:35pm (EST).
- Baird 2022 Global Healthcare Conference on Wednesday, September
14, 2022 at 8:30am (EST).
Links to the webcasts will be available on the Dexcom Investor
Relations website at investors.dexcom.com and will be archived
there for future reference.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of diabetes through
innovative continuous glucose monitoring (CGM) products.
Headquartered in San Diego, California, Dexcom has emerged as a
leader of diabetes care technology. By listening to the needs of
patients, caregivers, and clinicians, Dexcom simplifies and
improves diabetes management around the world.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220901005807/en/
DexCom, Inc. Sean Christensen Senior Director – Investor
Relations and Corporate FP&A investor-relations@dexcom.com
(858) 200-0200
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Aug 2024 to Sep 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Sep 2023 to Sep 2024